Alternative volumetric PET parameters for evaluation of breast cancer cases with 18F‐FDG PET/CT imaging: Metabolic tumour volume and total lesion glycolysis-Reference-Cited by-同舟云学术

Alternative volumetric PET parameters for evaluation of breast cancer cases with 18F‐FDG PET/CT imaging: Metabolic tumour volume and total lesion glycolysis

Published:2020-10-20 Issue:1 Volume:65 Page:38-45
ISSN:1754-9477
Container-title:Journal of Medical Imaging and Radiation Oncology
language:en
Short-container-title:J Med Imag Rad Onc

Author:

Arslan Esra¹^ORCID,Can Trabulus Didem²^ORCID,Mermut Özlem³^ORCID,Şavlı Taha Cumhan⁴^ORCID,Çermik Tevfik Fikret¹^ORCID

Affiliation:

1. Clinic of Nuclear Medicine University of Health and Sciences Turkey Istanbul Training and Research Hospital Istanbul Turkey

2. Clinic of Surgery University of Health and Sciences Turkey Istanbul Training and Research Hospital Istanbul Turkey

3. Department of Radiation Oncology University of Health and Sciences Turkey Istanbul Training and Research Hospital Istanbul Turkey

4. Department of Pathology University of Health and Sciences Turkey Istanbul Training and Research Hospital Istanbul Turkey

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1754-9485.13114

Reference22 articles.

1. Breast cancer prognosis signature: linking risk stratification to disease subtypes;Yu F;Brief Bioinform.,2018

2. Role of 18F-FDG PET/CT in evaluating molecular subtypes and clinicopathological features of primary breast cancer

3. Prognostic significance of high metabolic activity in breast cancer: PET signature in breast cancer

4. Association between semiquantitative PET parameters and molecular subtypes of breast invasive ductal carcinoma;Chiacchio S;Q J Nucl Med Mol Imaging.,2018

5. Quantitative assessment of metabolic tumor burden in molecular subtypes of primary breast cancer with FDG PET/CT

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovations in Positron Emission Tomography and State of the Art in the Evaluation of Breast Cancer Treatment Response;Journal of Clinical Medicine;2023-12-27

2. Investigation of Added Value of Imaging Performed in a Prone Position to Standard <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging for Staging in Patients with Breast Cancer;Molecular Imaging and Radionuclide Therapy;2022-02-02

3. Value of 18F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype;EJNMMI Research;2021-11-22